IGFBP5 and neoplasm: When we examined all the cell populations in our dataset, we confirmed minimal IGFBP3 expression in RCC tumor cells as well as IGFBP5 expression in pericytes, which have an overlapping gene expression signature with arterial smooth muscle cells (Supplementary Fig. 4A–C).